日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting Glutaminolysis Shows Efficacy in Both Prednisolone-Sensitive and in Metabolically Rewired Prednisolone-Resistant B-Cell Childhood Acute Lymphoblastic Leukaemia Cells

靶向谷氨酰胺分解疗法对泼尼松龙敏感型和代谢重编程的泼尼松龙耐药型B细胞儿童急性淋巴细胞白血病细胞均显示出疗效

Sbirkov, Yordan; Vergov, Bozhidar; Dzharov, Vasil; Schenk, Tino; Petrie, Kevin; Sarafian, Victoria

The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows In Vitro Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia

原生动物抑制剂阿托伐醌影响线粒体呼吸,并在体外对儿童B细胞急性淋巴细胞白血病中的糖皮质激素耐药细胞显示出疗效。

Sbirkov, Yordan; Ivanova, Tsvetomira; Burnusuzov, Hasan; Gercheva, Kalina; Petrie, Kevin; Schenk, Tino; Sarafian, Victoria

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

神经母细胞瘤精氨酸酶活性会形成免疫抑制微环境,从而损害自体免疫和工程化免疫

Mussai Francis, Egan Sharon, Hunter Stuart, Webber Hannah, Fisher Jonathan, Wheat Rachel, McConville Carmel, Sbirkov Yordan, Wheeler Kate, Bendle Gavin, Petrie Kevin, Anderson John, Chesler Louis, De Santo Carmela

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

细胞周期蛋白依赖性激酶抑制剂AT7519作为MYCN依赖性神经母细胞瘤的潜在药物

Dolman, M Emmy M; Poon, Evon; Ebus, Marli E; den Hartog, Ilona J M; van Noesel, Carel J M; Jamin, Yann; Hallsworth, Albert; Robinson, Simon P; Petrie, Kevin; Sparidans, Rolf W; Kok, Robbert J; Versteeg, Rogier; Caron, Huib N; Chesler, Louis; Molenaar, Jan J

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK

神经母细胞瘤治疗新策略:靶向MYCN和ALK的治疗

Barone, Giuseppe; Anderson, John; Pearson, Andrew D J; Petrie, Kevin; Chesler, Louis

Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics

沙漠中的抑郁症:癌症治疗中表观遗传学临床转化的第三次研讨会

Zelent, Arthur; Petrie, Kevin; Boix-Chornet, Manuel; Melnick, Ari M; Waxman, Samuel; Gore, Steven D